Tempus AI (TEM) FCF Margin (2023 - 2026)
Tempus AI's (TEM) quarterly FCF Margin came in at 3.57% in Q2 2026, down 1678.0% year-over-year from 0.23% in Q2 2025, and up 84.75% quarter-over-quarter from 23.41% in Q1 2026.
Powered by 
Analysis
Tempus AI (TEM) FCF Margin (2023 - 2026) Analysis & Trends
Tempus AI (TEM) has reported FCF Margin for 4 consecutive years, with 3.57% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin fell 1678.0% year-over-year to 3.57% in Q2 2026; TTM through Jun 2026 was 18.38%, a 1107.0% decrease from a year earlier, with the FY2025 full-year figure at 18.8%, up 1165.0% from the prior year.
- FCF Margin was 3.57% for Q2 2026 at Tempus AI, up from 23.41% in the prior quarter.
- Over five years, FCF Margin peaked at 26.87% in Q3 2024 and troughed at 73.71% in Q1 2024.
- A 4-year average of 26.7% and a median of 26.31% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin soared 7757 bps in 2024 and sank 6474 bps in 2025, its largest moves.
- Over 4 years, FCF Margin stood at 29.09% in 2023, then increased by 19 bps to 23.53% in 2024, then jumped by 52 bps to 11.31% in 2025, then soared by 68 bps to 3.57% in 2026.
- The last three FCF Margin figures came in at 3.57% (Q2 2026), 23.41% (Q1 2026), and 11.31% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.13 Bn | 46.03 Bn | 486.15 Mn | -1.15% |
| 2 | Labcorp Holdings | 26.44 Bn | 26.32 Bn | 1.11 Bn | 8.41% |
| 3 | Quest Diagnostics | 26.16 Bn | 25.84 Bn | 1.03 Bn | 15.08% |
| 4 | Guardant Health | 21.57 Bn | 20.51 Bn | 219.03 Mn | -20.76% |
| 5 | Tempus AI | 11.32 Bn | 10.51 Bn | 274.25 Mn | -3.57% |
| 6 | Caris Life Sciences | 7.08 Bn | 6.29 Bn | 182.38 Mn | 2.43% |
| 7 | Sotera Health | 5.39 Bn | 5.04 Bn | 177.96 Mn | 13.08% |
| 8 | BillionToOne | 4.65 Bn | 4.11 Bn | 77.11 Mn | 4.65% |
| 9 | iRhythm Holdings | 4.05 Bn | 3.46 Bn | 163.21 Mn | 16.73% |
| 10 | Adaptive Biotechnologies | 3.86 Bn | 3.53 Bn | 51.39 Mn | -10.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.57% |
| Mar 31, 2026 | -23.41% |
| Dec 31, 2025 | -11.31% |
| Sep 30, 2025 | -37.87% |
| Jun 30, 2025 | 13.21% |
| Mar 31, 2025 | -44.04% |
| Dec 31, 2024 | -23.53% |
| Sep 30, 2024 | 26.87% |
| Jun 30, 2024 | -63.32% |
| Mar 31, 2024 | -73.71% |
| Dec 31, 2023 | -29.09% |
| Sep 30, 2023 | -50.70% |